Investigation of a novel a cardiovascular inflammation marker, Pentraxin 3

在日本和工业国家，由心血管疾病引起的死亡率是最严重的。全科医生虽然不是心脏病专家，但他们应该对这种疾病做出诊断。心电图或超声心动图是诊断此类疾病的有用工具，但仍然需要特定的技术来进行诊断。我们建立了一种新的心血管标志物penttraxin 3 （PTX3）。仅0.1mL血样反映血管炎症状态。在本研究中，我们报道了PTX3是预测急性冠脉综合征或睡眠呼吸暂停综合征患者预后的有用指标。

In Japan as well as industry countries, the mortality caused by cardiovascular disease is worst. General practitioners are expected to make a diagnosis of such disease although they are not cardiologist. ECG or UCG are useful tools to make a diagnosis for such disease, but still, they require specific technique to make a diagnosis. We established a novel cardiovascular marker, Pentraxin 3 (PTX3). Only 0.1mL blood sample reflect the status of the inflammation of vascular. In this study, we have reported that PTX3 was a useful marker to predict the prognosis for patients with acute coronary syndrome, or sleep apnea syndrome.